AllianceBernstein’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-162,790
| Closed | -$553K | – | 3183 |
|
|
2018
Q3 | $553K | Sell |
162,790
-4,520
| -3% | -$16.3K | ﹤0.01% | 2576 |
|
|
2018
Q2 | $629K | Buy |
167,310
+13,960
| +9% | +$68K | ﹤0.01% | 2526 |
|
|
2018
Q1 | $627K | Buy |
153,350
+15,200
| +11% | +$70.8K | ﹤0.01% | 2449 |
|
|
2017
Q4 | $642K | Buy |
138,150
+510
| +0.4% | +$2.81K | ﹤0.01% | 2464 |
|
|
2017
Q3 | $977K | Sell |
137,640
-54,010
| -28% | -$388K | ﹤0.01% | 2293 |
|
|
2017
Q2 | $1.39M | Buy |
191,650
+54,010
| +39% | +$337K | ﹤0.01% | 2111 |
|
|
2017
Q1 | $848K | Sell |
137,640
-11,700
| -8% | -$64.1K | ﹤0.01% | 2322 |
|
|
2016
Q4 | $875K | Hold |
149,340
| – | – | ﹤0.01% | 2327 |
|
|
2016
Q3 | $793K | Sell |
149,340
-11,700
| -7% | -$63.1K | ﹤0.01% | 2331 |
|
|
2016
Q2 | $1.07M | Hold |
161,040
| – | – | ﹤0.01% | 2180 |
|
|
2016
Q1 | $752K | Sell |
161,040
-15,500
| -9% | -$61.9K | ﹤0.01% | 2254 |
|
|
2015
Q4 | $892K | Hold |
176,540
| – | – | ﹤0.01% | 2197 |
|
|
2015
Q3 | $621K | Sell |
176,540
-160
| -0.1% | -$1.07K | ﹤0.01% | 2404 |
|
|
2015
Q2 | $1.76M | Sell |
176,700
-1,600
| -0.9% | -$17.2K | ﹤0.01% | 1903 |
|
|
2015
Q1 | $2.27M | Buy |
178,300
+1,600
| +0.9% | +$20.6K | ﹤0.01% | 1632 |
|
|
2014
Q4 | $2.5M | Sell |
176,700
-5,600
| -3% | -$86.8K | ﹤0.01% | 1581 |
|
|
2014
Q3 | $2.51M | Hold |
182,300
| – | – | ﹤0.01% | 1544 |
|
|
2014
Q2 | $2.8M | Buy |
182,300
+30,700
| +20% | +$435K | ﹤0.01% | 1520 |
|
|
2014
Q1 | $2.58M | Sell |
151,600
-239
| -0.2% | -$3.61K | ﹤0.01% | 1514 |
|
|
2013
Q4 | $1.97M | Buy |
151,839
+2,037
| +1% | +$24.3K | ﹤0.01% | 1716 |
|
|
2013
Q3 | $1.51M | Buy |
149,802
+2
| +0% | +$18 | ﹤0.01% | 1882 |
|
|
2013
Q2 | $1.12M | Buy |
+149,800
| New | +$1.17M | ﹤0.01% | 2012 |
|
AllianceBernstein's KERX Position: Q4 2018 in Review
AllianceBernstein sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 162,790 shares — an estimated $553K sold.
AllianceBernstein first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $2.8M in Q2 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- AllianceBernstein reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- AllianceBernstein sold 162,790 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $553K.
- AllianceBernstein first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
- AllianceBernstein's Keryx Biopharmaceuticals Inc position peaked at $2.8M in Q2 2014.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on AllianceBernstein's 13F filing for Q4 2018, filed 13 Feb 2019.